Terms: = Liver cancer AND SYK, P43405, 6850, ENSG00000165025
43 results:
1. Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities.
Shaker ME; Gomaa HAM; Abdelgawad MA; El-Mesery M; Shaaban AA; Hazem SH
Int Immunopharmacol; 2023 Jul; 120():110373. PubMed ID: 37257270
[TBL] [Abstract] [Full Text] [Related]
2. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles JR; Wu JE; Chen Z; Huang YJ; Belman J; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
Front Immunol; 2022; 13():834988. PubMed ID: 35309299
[TBL] [Abstract] [Full Text] [Related]
3. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
4. Kinase Inhibition as Treatment for Acute and Chronic Graft-
Braun LM; Zeiser R
Front Immunol; 2021; 12():760199. PubMed ID: 34868001
[TBL] [Abstract] [Full Text] [Related]
5. Targeting syk of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment.
Chen X; Wang Z; Han S; Wang Z; Zhang Y; Li X; Xia N; Yu W; Jia C; Ni Y; Pu L
Cell Death Dis; 2021 Dec; 12(12):1123. PubMed ID: 34853322
[TBL] [Abstract] [Full Text] [Related]
6. Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis.
Hu Q; Liu M; You Y; Zhou G; Chen Y; Yuan H; Xie L; Han S; Zhu K
Free Radic Biol Med; 2021 Nov; 175():193-205. PubMed ID: 34492311
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors of patients after liver cancer surgery: Based on Surveillance, Epidemiology, and End Results database.
Liang F; Ma F; Zhong J
Medicine (Baltimore); 2021 Jul; 100(30):e26694. PubMed ID: 34397696
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
[TBL] [Abstract] [Full Text] [Related]
9. Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.
Nahm JH; Lee HS; Kim H; Yim SY; Shin JH; Yoo JE; Ahn SH; Choi JS; Lee JS; Park YN
Liver Int; 2021 Jul; 41(7):1662-1674. PubMed ID: 33638929
[TBL] [Abstract] [Full Text] [Related]
10. Recent Improvements in Racial Disparity in the Treatment of Hepatocellular Carcinoma: How Times Have Changed.
Moten AS; Fagenson AM; Pitt HA; Lau KN
J Gastrointest Surg; 2021 Oct; 25(10):2535-2544. PubMed ID: 33547582
[TBL] [Abstract] [Full Text] [Related]
11. Shear-wave velocity for colorectal cancer liver metastases as a potential prognostic factor after chemotherapy: a preliminary study.
Lee DH; Lee JY; Joo I; Kim TY; Han SW; Lee KH
Clin Radiol; 2021 Mar; 76(3):224-232. PubMed ID: 33402260
[TBL] [Abstract] [Full Text] [Related]
12. Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis.
Miao S; Lu M; Liu Y; Shu D; Zhu Y; Song W; Ma Y; Ma R; Zhang B; Fang C; Ming ZY
Mol Oncol; 2020 Oct; 14(10):2546-2559. PubMed ID: 32799418
[TBL] [Abstract] [Full Text] [Related]
13. A new clinical prognostic nomogram for liver cancer based on immune score.
Shen Q; Hu G; Wu J; Lv L
PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of the deubiquitinase USP10 induces degradation of syk.
Yang J; Meng C; Weisberg E; Case A; Lamberto I; Magin RS; Adamia S; Wang J; Gray N; Liu S; Stone R; Sattler M; Buhrlage S; Griffin JD
Br J Cancer; 2020 Apr; 122(8):1175-1184. PubMed ID: 32015510
[TBL] [Abstract] [Full Text] [Related]
15. Killing Effects of IFN R
Liang S; Lin X; Liang Y; Song D; Zhang L; Fan X
Anat Rec (Hoboken); 2019 Oct; 302(10):1718-1725. PubMed ID: 31120191
[TBL] [Abstract] [Full Text] [Related]
16. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
[TBL] [Abstract] [Full Text] [Related]
17. Targeting syk signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
Torres-Hernandez A; Wang W; Nikiforov Y; Tejada K; Torres L; Kalabin A; Wu Y; Haq MIU; Khan MY; Zhao Z; Su W; Camargo J; Hundeyin M; Diskin B; Adam S; Rossi JAK; Kurz E; Aykut B; Shadaloey SAA; Leinwand J; Miller G
Oncogene; 2019 Jun; 38(23):4512-4526. PubMed ID: 30742098
[TBL] [Abstract] [Full Text] [Related]
18. cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa.
Miao S; Shu D; Zhu Y; Lu M; Zhang Q; Pei Y; He AD; Ma R; Zhang B; Ming ZY
Cell Death Dis; 2019 Jan; 10(2):87. PubMed ID: 30692520
[TBL] [Abstract] [Full Text] [Related]
19. Hepatitis C Virus Mimics Effects of Glypican-3 on CD81 and Promotes Development of Hepatocellular Carcinomas via Activation of Hippo Pathway in Hepatocytes.
Xue Y; Mars WM; Bowen W; Singhi AD; Stoops J; Michalopoulos GK
Am J Pathol; 2018 Jun; 188(6):1469-1477. PubMed ID: 29577937
[TBL] [Abstract] [Full Text] [Related]
20. Tyrosine kinase syk is a potential therapeutic target for liver fibrosis.
Qu C; Zheng D; Li S; Liu Y; Lidofsky A; Holmes JA; Chen J; He L; Wei L; Liao Y; Yuan H; Jin Q; Lin Z; Hu Q; Jiang Y; Tu M; Chen X; Li W; Lin W; Fuchs BC; Chung RT; Hong J
Hepatology; 2018 Sep; 68(3):1125-1139. PubMed ID: 29537660
[TBL] [Abstract] [Full Text] [Related]
[Next]
